BJAB Cells
US$ 395,00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Informações gerais
| Descrição | The BJAB cell line was established in 1973 from a 5-year-old African girl diagnosed with Epstein-Barr virus (EBV)-negative Burkitt’s lymphoma. This specific origin is crucial for research as it provides a distinct model for studying Burkitt’s lymphoma in the absence of EBV influence, which is common in many other lymphoma cell lines. The EBV-negative status of BJAB cells allows researchers to investigate the genetic and environmental factors contributing to lymphomagenesis without the confounding effects of the virus. BJAB cells are often used in oncological research, especially for exploring the pathophysiology of Burkitt's lymphoma, and for testing therapeutic strategies against it. The cell line displays many of the hallmark features of Burkitt’s lymphoma, including high proliferation rates and a characteristic immunophenotype. Its genetic stability and the robustness with which it can be cultured make it a valuable tool for in vitro experiments aimed at understanding lymphoma biology and assessing the efficacy of anti-cancer drugs. |
|---|---|
| Organismo | Human |
| Tecido | Blood |
| Doença | Burkitt lymphoma |
| Aplicações | Analysis of B cell surface antigens, testing of cytotoxic drugs, mutational analysis, analysis of apoptotic mechanisms, HLA-typing |
| Sinônimos | BJAb, BJA-B, BJAB-1, BJA-B1, BJA-B-1 |
Características
| Idade | 5 years |
|---|---|
| Gênero | Female |
| Etnia | African |
| Morfologia | Round cells |
| Tipo de célula | B lymphoblast |
| Propriedades de crescimento | Suspension |
Dados regulatórios
| Referência | BJAB (Cytion catalog number 302006) |
|---|---|
| Nível de biossegurança | 1 |
| NCBI_TaxID | 9606 |
| Número de acesso do Cellosaurus | CVCL_5711 |
Dados biomoleculares
| Expressão de antígenos | CD10+, CD19+, CD20+, CD21(+), CD22+, CD23-, CD24-, CD32+, CD37+, CD38+, CD39-, CD40+, CD54+, CD72+, CD73-, CD75+, CD77+, CD81, CD82+, CD83+, CD84+, CD86+ |
|---|---|
| Cariótipo | 46, hypodiploid |
Manuseio
| Meio de cultura | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 20% FBS, 10 mM HEPES |
| Subcultura | Maintain cultures by periodically adding or replacing the medium. Initiate cultures with a density of 5 x 105 cells/ml and keep the cell concentration within the range of 3 x 105 to 1 x 106 cells/ml for optimal growth. |
| Densidade de semeadura | 3 x 105 cells/ml |
| Renovação de fluidos | Every 3 to 5 days |
| Recuperação pós-degelo | Allow the cells to recover from the freezing process for at least 48 hours. |
| Meio de congelamento | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelamento e cultura de células |
|
| Atmosfera de incubação | 37°C, 5% CO2, humidified atmosphere. |
| Condições de envio | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condições de armazenamento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Controle de Qualidade e Análise Molecular
| Esterilidade | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de Análise (CoA)
| Número do lote | Tipo de certificado | Data | Número de catálogo |
|---|---|---|---|
| 302006-201223 | Certificado de Análise | 23. May. 2025 | 302006 |
| 302006-240125 | Certificado de Análise | 23. May. 2025 | 302006 |
| 302006-040326 | Certificado de Análise | 08. Apr. 2026 | 302006 |